tadalafil has been researched along with fosmidomycin in 1 studies
| Studies (tadalafil) | Trials (tadalafil) | Recent Studies (post-2010) (tadalafil) | Studies (fosmidomycin) | Trials (fosmidomycin) | Recent Studies (post-2010) (fosmidomycin) |
|---|---|---|---|---|---|
| 1,742 | 392 | 1,089 | 243 | 10 | 116 |
| Protein | Taxonomy | tadalafil (IC50) | fosmidomycin (IC50) |
|---|---|---|---|
| 1-deoxy-D-xylulose 5-phosphate reductoisomerase | Mycolicibacterium smegmatis MC2 155 | 0.295 | |
| 1-deoxy-D-xylulose 5-phosphate reductoisomerase | Escherichia coli K-12 | 0.0334 | |
| 1-deoxy-D-xylulose 5-phosphate reductoisomerase | Mycobacterium tuberculosis H37Rv | 0.165 | |
| 1-deoxy-D-xylulose 5-phosphate reductoisomerase, chloroplastic | Arabidopsis thaliana (thale cress) | 0.1 | |
| 1-deoxy-D-xylulose 5-phosphate reductoisomerase | Escherichia coli | 0.438 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carlier, PR; Cassera, MB; Krai, PM; Merino, EF; Simpson, ME; Slebodnick, C; Yao, ZK | 1 |
1 other study(ies) available for tadalafil and fosmidomycin
| Article | Year |
|---|---|
Determination of the active stereoisomer of the MEP pathway-targeting antimalarial agent MMV008138, and initial structure-activity studies.
Topics: Antimalarials; Carbolines; Dose-Response Relationship, Drug; Erythritol; Molecular Structure; Parasitic Sensitivity Tests; Pipecolic Acids; Plasmodium falciparum; Stereoisomerism; Structure-Activity Relationship; Sugar Phosphates | 2015 |